Literature DB >> 27080631

[Not Available].

Mira Pavlovic1, Jérôme Garnier2, Isabelle Durand-Zaleski3.   

Abstract

Keywords:  Haute Autorité de santé; IQWIG; NICE; Oncologie; Ratio différentiel coût-résultat; Survie; Survie sans progression; Évaluation médicoéconomique

Mesh：

Year:  2016        PMID： 27080631     DOI： 10.1016/j.therap.2015.12.002

Source DB:  PubMed          Journal:  Therapie        ISSN： 0040-5957            Impact factor:   2.070


× No keyword cloud information.
  1 in total

1.  Challenges for Relative Effectiveness Assessment and Early Access of Cancer Immunotherapies in Europe.

Authors:  Mira Pavlovic
Journal:  Front Med (Lausanne)       Date:  2016-11-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.